Insider Trading July 6, 2026 07:12 PM

Symbotic Director Charles Kane Disposes of $89,800 in Equity via Pre-Arranged Plan

Executive sale coincides with ongoing stock volatility and recent Q2 fiscal results, highlighting shifting insider positions amid strategic portfolio expansion.

By Sofia Navarro
Share
Twitter Reddit Facebook LinkedIn
SYM

Symbotic Inc. (NASDAQ:SYM) Director Charles Kane executed a sale of 2,000 Class A Common Stock shares on July 1, 2026, generating $89,800 through a 10b5-1 trading plan. The transaction involved redeeming Symbotic Holdings Units, which were subsequently canceled. This move occurs against a backdrop of recent stock depreciation and mixed Q2 fiscal 2026 financial results, where revenue exceeded forecasts despite an earnings per share miss. The company continues to navigate market fluctuations while expanding its technology footprint through strategic acquisitions.

Symbotic Director Charles Kane Disposes of $89,800 in Equity via Pre-Arranged Plan
SYM
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Director Charles Kane sold 2,000 shares via a 10b5-1 plan, reducing direct holdings while maintaining a significant position in redeemable Symbotic Holdings Units.
  • Symbotic reported mixed Q2 fiscal 2026 results, missing EPS expectations but surpassing revenue forecasts, which contrasts with the recent 37% stock decline.
  • The company expanded its technology portfolio through the acquisition of ARMS, receiving positive analyst coverage from Oppenheimer with an $84.00 price target.

Symbotic Inc. (NASDAQ:SYM) director Charles Kane has executed a significant equity transaction, selling 2,000 shares of Class A Common Stock on July 1, 2026. The disposal of these shares generated a total transaction value of $89,800, with the shares priced at $44.90 each. This specific sale was carried out under the parameters of a pre-arranged trading plan, which was originally established on December 8, 2025, and operates in compliance with Rule 10b5-1 of the Securities Exchange Act of 1934.

The timing of this transaction is notable given the recent performance of Symbotic's equity. The stock has experienced a 37% decline over the preceding six months. Despite this downward trajectory, current market data indicates that Symbotic's shares are trading below the InvestingPro Fair Value estimate, a metric that suggests potential upside for market participants. At the time of the sale, the stock closed at $44.46, a figure closely aligned with the execution price of Kane's transaction.

Structurally, the sale was facilitated through the redemption of 2,000 Symbotic Holdings Units. These units, which represent limited liability company interests in Symbotic Holdings LLC paired with Class V-1 Common Stock shares, were exchanged for an equal number of Class A Common Stock shares. This redemption occurred on a one-for-one basis, subject to specific adjustments. Following the exchange, the Symbotic Holdings Units were canceled, and the associated 2,000 shares of Class V-1 Common Stock, which carry no economic rights, were also canceled and retired without consideration.

Post-transaction, Mr. Kane's direct holdings in Symbotic Inc. Class A Common Stock stand at 89,852 shares. Additionally, he retains 587,353 Symbotic Holdings Units, which remain redeemable for Class A Common Stock on a one-for-one basis. This position underscores the complex structure of insider holdings within the company, balancing direct equity with redeemable units.

Insider activity extends beyond Mr. Kane. Director Todd Krasnow has also been active in the market, selling 19,655 shares of Class A Common Stock, followed by an additional sale of 6,978 shares. These transactions were formally reported in filings with the Securities and Exchange Commission, highlighting a broader pattern of insider selling activity within the firm.

These sales coincide with Symbotic's recent financial reporting for the second quarter of fiscal year 2026. The results presented a mixed financial picture. The company missed analyst expectations for earnings per share, reporting $0.01 against a forecasted $0.12. However, top-line performance outpaced projections, with revenue reaching $676 million compared to the anticipated $662.66 million.

Strategic developments also played a role in the recent market narrative. Symbotic expanded its technology portfolio through the acquisition of ARMS, a coordination software provider. This move was positively received by Oppenheimer, which reiterated an Outperform rating for the stock and established a price target of $84.00. The acquisition and revenue performance may provide insights into Symbotic's strategic direction and future potential.

Market data indicates Symbotic closed at $44.46, reflecting a 1.720 point increase or 4.02% gain. After-hours trading showed a stable price of $44.460. The stock's performance over the past six months highlights the volatility inherent in the sector, with the recent decline contrasting with the strategic expansion and revenue growth reported in the latest quarter.

Risks

  • The stock has declined 37% over the past six months, indicating significant volatility and potential downward pressure on investor sentiment.
  • The company missed earnings per share expectations, posting $0.01 versus the forecasted $0.12, which may signal underlying operational challenges or margin pressures.
  • Insider selling activity, including transactions by Director Todd Krasnow, may reflect a cautious stance toward short-term valuation or future market conditions.

More from Insider Trading

Snowflake Director Benoit Dageville Offloads $48.6M in Shares Amid Valuation Concerns Jul 6, 2026 Snowflake Executive Christian Kleinerman Executes $646,400 Stock Sale Under Pre-Arranged Plan Jul 6, 2026 GameStop Executive Daniel Moore Sells Shares Amid Strategic Shifts and Record Earnings Jul 6, 2026 Freshworks Executive Transaction Highlights AI Strategic Shift Amid Valuation Debate Jul 6, 2026 Palisade Bio Director Robert Baltera Jr. Expands Position as FDA Clears Phase 2 Trial Jul 6, 2026